[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Non-small Cell Lung Cancer Therapeutics Market Report 2016

November 2016 | 117 pages | ID: UF2C368601AEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Non-small Cell Lung Cancer Therapeutics

Revenue, means the sales value of Non-small Cell Lung Cancer Therapeutics

This report studies sales (consumption) of Non-small Cell Lung Cancer Therapeutics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Bristol-Myers Squibb
  • GlaxoSmithKline
  • Menarini
  • Sanofi
  • ZIOPHARM Oncology
  • Alchemia
  • Amgen
  • Apotex
  • BioMarin Pharmaceutical
  • CellAct Pharma
  • Cerulean Pharma
  • Cipla
  • Cornerstone Pharmaceuticals
  • Curis
  • CytRx
  • Eli Lilly
  • Exelixis
  • Fresenius Kabi
  • Genentech
  • Hikma Pharmaceuticals
  • Hospira
  • Intas Pharmaceuticals
  • Karyopharm Therapeutics
  • Kyowa Hakko Kirin
  • Ligand Pharmaceuticals
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Non-small Cell Lung Cancer Therapeutics in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States Non-small Cell Lung Cancer Therapeutics Market Report 2016

1 NON-SMALL CELL LUNG CANCER THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Non-small Cell Lung Cancer Therapeutics
1.2 Classification of Non-small Cell Lung Cancer Therapeutics
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Non-small Cell Lung Cancer Therapeutics
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Non-small Cell Lung Cancer Therapeutics (2011-2021)
  1.4.1 United States Non-small Cell Lung Cancer Therapeutics Sales and Growth Rate (2011-2021)
  1.4.2 United States Non-small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2011-2021)

2 UNITED STATES NON-SMALL CELL LUNG CANCER THERAPEUTICS COMPETITION BY MANUFACTURERS

2.1 United States Non-small Cell Lung Cancer Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Non-small Cell Lung Cancer Therapeutics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Non-small Cell Lung Cancer Therapeutics Average Price by Manufactures (2015 and 2016)
2.4 Non-small Cell Lung Cancer Therapeutics Market Competitive Situation and Trends
  2.4.1 Non-small Cell Lung Cancer Therapeutics Market Concentration Rate
  2.4.2 Non-small Cell Lung Cancer Therapeutics Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES NON-SMALL CELL LUNG CANCER THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Non-small Cell Lung Cancer Therapeutics Sales and Market Share by Type (2011-2016)
3.2 United States Non-small Cell Lung Cancer Therapeutics Revenue and Market Share by Type (2011-2016)
3.3 United States Non-small Cell Lung Cancer Therapeutics Price by Type (2011-2016)
3.4 United States Non-small Cell Lung Cancer Therapeutics Sales Growth Rate by Type (2011-2016)

4 UNITED STATES NON-SMALL CELL LUNG CANCER THERAPEUTICS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Non-small Cell Lung Cancer Therapeutics Sales and Market Share by Application (2011-2016)
4.2 United States Non-small Cell Lung Cancer Therapeutics Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES NON-SMALL CELL LUNG CANCER THERAPEUTICS MANUFACTURERS PROFILES/ANALYSIS

5.1 Bristol-Myers Squibb
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Non-small Cell Lung Cancer Therapeutics Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 GlaxoSmithKline
  5.2.2 Non-small Cell Lung Cancer Therapeutics Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Menarini
  5.3.2 Non-small Cell Lung Cancer Therapeutics Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Menarini Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Sanofi
  5.4.2 Non-small Cell Lung Cancer Therapeutics Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Sanofi Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 ZIOPHARM Oncology
  5.5.2 Non-small Cell Lung Cancer Therapeutics Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 ZIOPHARM Oncology Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Alchemia
  5.6.2 Non-small Cell Lung Cancer Therapeutics Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Alchemia Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Amgen
  5.7.2 Non-small Cell Lung Cancer Therapeutics Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Amgen Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Apotex
  5.8.2 Non-small Cell Lung Cancer Therapeutics Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Apotex Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 BioMarin Pharmaceutical
  5.9.2 Non-small Cell Lung Cancer Therapeutics Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 BioMarin Pharmaceutical Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 CellAct Pharma
  5.10.2 Non-small Cell Lung Cancer Therapeutics Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 CellAct Pharma Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Cerulean Pharma
5.12 Cipla
5.13 Cornerstone Pharmaceuticals
5.14 Curis
5.15 CytRx
5.16 Eli Lilly
5.17 Exelixis
5.18 Fresenius Kabi
5.19 Genentech
5.20 Hikma Pharmaceuticals
5.21 Hospira
5.22 Intas Pharmaceuticals
5.23 Karyopharm Therapeutics
5.24 Kyowa Hakko Kirin
5.25 Ligand Pharmaceuticals

6 NON-SMALL CELL LUNG CANCER THERAPEUTICS MANUFACTURING COST ANALYSIS

6.1 Non-small Cell Lung Cancer Therapeutics Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Non-small Cell Lung Cancer Therapeutics

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Non-small Cell Lung Cancer Therapeutics Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Non-small Cell Lung Cancer Therapeutics Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET FORECAST (2016-2021)

10.1 United States Non-small Cell Lung Cancer Therapeutics Sales, Revenue Forecast (2016-2021)
10.2 United States Non-small Cell Lung Cancer Therapeutics Sales Forecast by Type (2016-2021)
10.3 United States Non-small Cell Lung Cancer Therapeutics Sales Forecast by Application (2016-2021)
10.4 Non-small Cell Lung Cancer Therapeutics Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Non-small Cell Lung Cancer Therapeutics
Table Classification of Non-small Cell Lung Cancer Therapeutics
Figure United States Sales Market Share of Non-small Cell Lung Cancer Therapeutics by Type in 2015
Table Application of Non-small Cell Lung Cancer Therapeutics
Figure United States Sales Market Share of Non-small Cell Lung Cancer Therapeutics by Application in 2015
Figure United States Non-small Cell Lung Cancer Therapeutics Sales and Growth Rate (2011-2021)
Figure United States Non-small Cell Lung Cancer Therapeutics Revenue and Growth Rate (2011-2021)
Table United States Non-small Cell Lung Cancer Therapeutics Sales of Key Manufacturers (2015 and 2016)
Table United States Non-small Cell Lung Cancer Therapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Non-small Cell Lung Cancer Therapeutics Sales Share by Manufacturers
Figure 2016 Non-small Cell Lung Cancer Therapeutics Sales Share by Manufacturers
Table United States Non-small Cell Lung Cancer Therapeutics Revenue by Manufacturers (2015 and 2016)
Table United States Non-small Cell Lung Cancer Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Non-small Cell Lung Cancer Therapeutics Revenue Share by Manufacturers
Table 2016 United States Non-small Cell Lung Cancer Therapeutics Revenue Share by Manufacturers
Table United States Market Non-small Cell Lung Cancer Therapeutics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Non-small Cell Lung Cancer Therapeutics Average Price of Key Manufacturers in 2015
Figure Non-small Cell Lung Cancer Therapeutics Market Share of Top 3 Manufacturers
Figure Non-small Cell Lung Cancer Therapeutics Market Share of Top 5 Manufacturers
Table United States Non-small Cell Lung Cancer Therapeutics Sales by Type (2011-2016)
Table United States Non-small Cell Lung Cancer Therapeutics Sales Share by Type (2011-2016)
Figure United States Non-small Cell Lung Cancer Therapeutics Sales Market Share by Type in 2015
Table United States Non-small Cell Lung Cancer Therapeutics Revenue and Market Share by Type (2011-2016)
Table United States Non-small Cell Lung Cancer Therapeutics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Non-small Cell Lung Cancer Therapeutics by Type (2011-2016)
Table United States Non-small Cell Lung Cancer Therapeutics Price by Type (2011-2016)
Figure United States Non-small Cell Lung Cancer Therapeutics Sales Growth Rate by Type (2011-2016)
Table United States Non-small Cell Lung Cancer Therapeutics Sales by Application (2011-2016)
Table United States Non-small Cell Lung Cancer Therapeutics Sales Market Share by Application (2011-2016)
Figure United States Non-small Cell Lung Cancer Therapeutics Sales Market Share by Application in 2015
Table United States Non-small Cell Lung Cancer Therapeutics Sales Growth Rate by Application (2011-2016)
Figure United States Non-small Cell Lung Cancer Therapeutics Sales Growth Rate by Application (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Menarini Basic Information List
Table Menarini Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Menarini Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table ZIOPHARM Oncology Basic Information List
Table ZIOPHARM Oncology Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table ZIOPHARM Oncology Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Alchemia Basic Information List
Table Alchemia Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alchemia Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Apotex Basic Information List
Table Apotex Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Apotex Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table BioMarin Pharmaceutical Basic Information List
Table BioMarin Pharmaceutical Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioMarin Pharmaceutical Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table CellAct Pharma Basic Information List
Table CellAct Pharma Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table CellAct Pharma Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Cerulean Pharma Basic Information List
Table Cerulean Pharma Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cerulean Pharma Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Cipla Basic Information List
Table Cipla Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cipla Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Cornerstone Pharmaceuticals Basic Information List
Table Cornerstone Pharmaceuticals Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cornerstone Pharmaceuticals Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Curis Basic Information List
Table Curis Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Curis Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table CytRx Basic Information List
Table CytRx Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table CytRx Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Exelixis Basic Information List
Table Exelixis Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Exelixis Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Fresenius Kabi Basic Information List
Table Fresenius Kabi Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fresenius Kabi Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Hikma Pharmaceuticals Basic Information List
Table Hikma Pharmaceuticals Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hikma Pharmaceuticals Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hospira Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Intas Pharmaceuticals Basic Information List
Table Intas Pharmaceuticals Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Intas Pharmaceuticals Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Karyopharm Therapeutics Basic Information List
Table Karyopharm Therapeutics Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Karyopharm Therapeutics Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyowa Hakko Kirin Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Ligand Pharmaceuticals Basic Information List
Table Ligand Pharmaceuticals Non-small Cell Lung Cancer Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ligand Pharmaceuticals Non-small Cell Lung Cancer Therapeutics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-small Cell Lung Cancer Therapeutics
Figure Manufacturing Process Analysis of Non-small Cell Lung Cancer Therapeutics
Figure Non-small Cell Lung Cancer Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Non-small Cell Lung Cancer Therapeutics Major Manufacturers in 2015
Table Major Buyers of Non-small Cell Lung Cancer Therapeutics
Table Distributors/Traders List
Figure United States Non-small Cell Lung Cancer Therapeutics Production and Growth Rate Forecast (2016-2021)
Figure United States Non-small Cell Lung Cancer Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table United States Non-small Cell Lung Cancer Therapeutics Production Forecast by Type (2016-2021)
Table United States Non-small Cell Lung Cancer Therapeutics Consumption Forecast by Application (2016-2021 )

More Publications

Need Help?

Ask a Question

Market Reports

All Categories